Dyne Therapeutics's latest marketcap:
As of 07/09/2025, Dyne Therapeutics's market capitalization has reached $1.19 B. According to our data, Dyne Therapeutics is the 8706th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 1.19 B |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -367,130,000 |
| Shares Out | 141.51 M |
| EPS (ttm) | -3.62 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/11/2025 |
Dyne Therapeutics's yearly market capitalization.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 07/09/2025 | $1.19 B | -51.72% | 8706 |
| 12/31/2024 | $2.4 B | 193.72% | 5066 |
| 12/29/2023 | $816.3 M | 35.12% | 9839 |
| 12/30/2022 | $604.12 M | -0.31% | 11064 |
| 12/31/2021 | $606.03 M | -36.5% | 12175 |
| 12/31/2020 | $954.35 M | 8184 |
Company Profile
About Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing innovative therapeutics for genetically driven muscle diseases. Headquartered in Waltham, Massachusetts, the company was founded in 2017 and focuses on addressing unmet medical needs in neuromuscular disorders.
Key Focus Areas
- Myotonic Dystrophy Type 1
- Duchenne Muscular Dystrophy
- Facioscapulohumeral Dystrophy
- Pompe Disease
- Rare skeletal muscle disorders
- Cardiac and metabolic muscle diseases
Technology Platform
The company leverages its proprietary FORCE platform to deliver disease-modifying therapeutics designed to target the root causes of muscle diseases. This innovative approach aims to provide transformative treatments for patients with limited or no therapeutic options.
Dyne Therapeutics is committed to advancing its pipeline of muscle disease therapies through cutting-edge research and clinical development.
Frequently Asked Questions
-
What is Dyne Therapeutics's (DYN) current market cap?As of 07/09/2025, Dyne Therapeutics (including the parent company, if applicable) has an estimated market capitalization of $1.19 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Dyne Therapeutics (DYN) rank globally by market cap?Dyne Therapeutics global market capitalization ranking is approximately 8706 as of 07/09/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.